Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2008
Phase I clinical trial of i.v. ascorbic acid in advanced malignancyL J Hoffer, M Levine, S Assouline, et al.
Nuclear Medicine and Biology|February 19, 2014
166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabelS Thompson, B Ballard, Z Jiang, et al.
Cancer Research|December 15, 1994
9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and proteinM Rubin, E Fenig, A Rosenauer, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1987
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptaseM H St Clair, C A Richards, T Spector, et al.
Cell|September 2, 1991
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PMLA Kakizuka, W H Miller, K Umesono, et al.
The Journal of Clinical Investigation|May 20, 1999
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatmentD J Park, A M Chumakov, P T Vuong, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1980
Percutaneous transluminal angioplasty in the management of occlusive disease involving the coronary arteries and saphenous vein bypass grafts: preliminary resultsW B Ford, M H Wholey, E A Zikria, et al.
British Journal of Cancer|October 6, 2011
Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence scoreS Sahebjam, R Aloyz, D Pilavdzic, et al.
Oncogene|December 1, 1993
Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cellJ Baselga, W J Maerz, D Moy, et al.
Pageof 25